GFAP and diabetes mellitus: In order to evaluate the potential anti-inflammatory properties and effect on glial cell reactivity, VEGF-α, GFAP, and VCAM-1 mRNA levels were analyzed by FQ-PCR after 42-d treatment (72 d of total duration of diabetes).